Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Increase aspirin use for secondary prevention of atherosclerotic cardiovascular disease — HDS‑08 Data

National Status: Little or no detectable change

  
Learn more about our data release schedule

Most Recent Data:
69.0 percent (2017-20) *

National Target:
69.4 percent  1  *

Desired Direction:
Increase desired

National Baseline:
63.5 percent of adults aged 40 years and over with a history of cardiovascular disease were using aspirin in 2013-16 2 *

* Age adjusted to the year 2000 standard population.

Disparities data are only available for some selections.

View CI in the chart by hovering over a data point.

View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

Display data for:

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Total
63.5
CI 60.4 / 66.5
SE 2.116
69.0
CI 63.6 / 74.1
SE 4.081

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Sex, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Male
66.3
CI 62.2 / 70.2
SE 2.680
77.9
CI 72.6 / 82.6
SE 4.229
Female
60.4
CI 54.1 / 66.5
SE 4.172
59.2
CI 53.5 / 64.7
SE 3.503

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Race/Ethnicity, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
American Indian or Alaska Native only
DSU
DSU
Asian only
DSU
DSU
Native Hawaiian or Other Pacific Islander only
DSU
DSU
Black or African American only
DNA
DNA
White only
DNA
DNA
2 or more races
DSU
DSU
Hispanic or Latino
55.4
CI 48.3 / 62.4
SE 4.275
67.0
CI 57.5 / 75.5
SE 5.893
Mexican American
55.6
CI 45.4 / 65.6
SE 5.567
DSU
Not Hispanic or Latino
DNA
DNA
American Indian or Alaska Native only, not Hispanic or Latino
DSU
DSU
Asian only, not Hispanic or Latino
70.4
CI 55.3 / 82.9
SE 7.837
54.3
CI 41.0 / 67.3
SE 6.791
Native Hawaiian or Other Pacific Islander only, not Hispanic or Latino
DSU
DSU
Black or African American only, not Hispanic or Latino
73.8
CI 67.2 / 79.7
SE 2.977
69.9
CI 61.6 / 77.4
SE 5.880
White only, not Hispanic or Latino
60.5
CI 55.9 / 64.9
SE 3.170
70.1
CI 63.4 / 76.3
SE 5.615
2 or more races, not Hispanic or Latino
DSU
DSU

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Age group, 2013-16 to 2017-20 † ◊
(percent)
Increase desired

Population 2013-16 2017-203
40-44 years
DSU
DSU
45-64 years
68.6
CI 61.3 / 75.2
SE 3.296
74.0
CI 65.2 / 81.5
SE 3.809
45-54 years
DSU
DSU
55-64 years
73.0
CI 65.1 / 79.9
SE 3.477
80.0
CI 71.4 / 87.0
SE 3.627
65 years and over
83.8
CI 79.0 / 87.9
SE 2.114
82.7
CI 76.7 / 87.7
SE 2.549
65-74 years
84.2
CI 77.0 / 89.8
SE 2.991
78.6
CI 68.9 / 86.5
SE 4.060
75-79 years
89.7
CI 82.2 / 94.8
SE 2.191
91.54
CI 84.3 / 96.1
SE 2.380
80 years and over
80.5
CI 72.2 / 87.2
SE 3.491
85.8
CI 77.1 / 92.2
SE 3.427

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Educational attainment, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Less than High school
57.3
CI 51.4 / 63.1
SE 3.667
70.8
CI 63.2 / 77.6
SE 5.460
High school (including GED or equivalent)
60.0
CI 53.5 / 66.2
SE 3.688
73.8
CI 64.9 / 81.5
SE 6.550
Some college or Associate degree
65.0
CI 58.4 / 71.2
SE 5.119
63.2
CI 57.3 / 68.8
SE 3.852
4-year college degree or more
71.1
CI 60.5 / 80.3
SE 7.170
68.1
CI 58.4 / 76.8
SE 7.997

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Family income (percent poverty guidelines), 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
<100
63.7
CI 54.9 / 71.9
SE 5.700
62.0
CI 52.1 / 71.1
SE 5.795
100-199
62.1
CI 54.5 / 69.3
SE 5.128
63.6
CI 56.1 / 70.7
SE 5.520
200-399
55.5
CI 48.6 / 62.2
SE 3.388
68.8
CI 56.2 / 79.6
SE 8.839
400+
70.0
CI 59.3 / 79.3
SE 9.494
79.6
CI 72.7 / 85.3
SE 5.607

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Health insurance status (40-64 years), 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Insured
55.7
CI 49.3 / 62.0
SE 4.094
63.5
CI 53.4 / 72.8
SE 6.334
Private
54.7
CI 43.9 / 65.2
SE 6.173
DSU
Public
56.9
CI 47.0 / 66.5
SE 6.598
54.5
CI 46.1 / 62.7
SE 5.702
Uninsured
50.4
CI 36.2 / 64.5
SE 7.160
DSU

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Geographic location, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Geographic location
DNC
DNC

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Marital status, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Married/​Cohabiting partner
67.0
CI 62.7 / 71.0
SE 2.954
70.4
CI 63.5 / 76.6
SE 4.911
Divorced, separated, widowed
58.1
CI 51.6 / 64.4
SE 6.130
63.2
CI 57.1 / 69.1
SE 4.916
Never married
61.7
CI 47.0 / 75.0
SE 7.043
72.8
CI 57.3 / 85.0
SE 7.330

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Country of birth, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
US
64.3
CI 60.8 / 67.7
SE 2.104
69.0
CI 63.3 / 74.2
SE 4.152
Outside US
56.0
CI 48.5 / 63.4
SE 5.444
70.8
CI 58.6 / 81.2
SE 9.635

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Veteran status, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Veteran
71.8
CI 63.9 / 78.9
SE 9.646
DNA
Non-veteran
62.3
CI 58.7 / 65.8
SE 2.438
DNA

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Activity limitation, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
With activity limitations
61.4
CI 56.3 / 66.2
SE 3.993
DNC
Without activity limitations
65.8
CI 60.4 / 70.9
SE 3.622
DNC

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Sexual orientation, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Sexual orientation
DSU
DSU

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Gender identity, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
Gender identity
DNC
DNC

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Obesity status, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
With obesity
65.4
CI 60.4 / 70.0
SE 3.013
71.6
CI 64.4 / 78.1
SE 4.691
Without obesity
64.3
CI 59.3 / 69.0
SE 4.118
62.4
CI 54.7 / 69.7
SE 6.630

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by Diabetes status, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-203
With diabetes
76.9
CI 71.8 / 81.5
SE 4.309
76.8
CI 69.8 / 82.8
SE 6.246
Without diabetes
59.3
CI 55.4 / 63.2
SE 2.669
65.2
CI 59.0 / 71.1
SE 4.252

Disparity